MariMed Inc. (OTCMKTS:MRMD) Sees Large Growth in Short Interest

MariMed Inc. (OTCMKTS:MRMD) saw a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 9,792 shares, a growth of 151.5% from the July 15th total of 3,893 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 433,915 shares, the days-to-cover ratio is currently 0.0 days.

MariMed Price Performance

Shares of MRMD opened at $0.07 on Friday. MariMed has a 12-month low of $0.06 and a 12-month high of $0.23. The business has a 50-day simple moving average of $0.07 and a two-hundred day simple moving average of $0.08. The company has a quick ratio of 0.34, a current ratio of 0.95 and a debt-to-equity ratio of 1.67. The stock has a market cap of $26.08 million, a PE ratio of -1.62 and a beta of 1.33.

MariMed (OTCMKTS:MRMD) last released its quarterly earnings results on Wednesday, August 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). MariMed had a negative net margin of 9.13% and a negative return on equity of 10.33%. The firm had revenue of $41.92 million during the quarter, compared to analyst estimates of $39.80 million.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.